High insulin levels linked to deaths from breast cancerBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7248.1496/a (Published 03 June 2000) Cite this as: BMJ 2000;320:1496
- Deborah Josefson
- San Francisco
High fasting concentrations of insulin may be an independent risk factor for poor outcomes in women with breast cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, in New Orleans, Louisiana. The study shedssome light on cell growth and may lead to new therapeutic avenues.
Researchers from the University of Toronto Mount Sinai Hospital led by Dr Pamela Goodwin followed 535 women with breast cancer for 10 years and studied the relation between breast cancer grade and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial